Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Emory University
Emory University
National Cancer Institute (NCI)
NRG Oncology
First Affiliated Hospital of Wenzhou Medical University
Fudan University
Centre Paul Strauss
Fudan University
Shanghai Tongji Hospital, Tongji University School of Medicine
Fudan University
Replimune Inc.
Children's Oncology Group
Herlev Hospital
M.D. Anderson Cancer Center
IFOM ETS - The AIRC Institute of Molecular Oncology
IFOM ETS - The AIRC Institute of Molecular Oncology
Sichuan University
National Health Research Institutes, Taiwan
NRG Oncology
Tempus AI
Tempus AI